Retlich, Silke <br/><br/>
Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects.  [electronic resource] 

 -  Clinical pharmacokinetics  Dec 2010 
 - 829-40 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-1926 
<br/><br/><label>Standard No.: </label>10.2165/11536620-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Area Under Curve<br/>Biological Availability<br/>Cross-Over Studies<br/>Dipeptidyl Peptidase 4--metabolism<br/>Dipeptidyl-Peptidase IV Inhibitors--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Half-Life<br/>Humans<br/>Infusions, Intravenous<br/>Linagliptin<br/>Male<br/>Middle Aged<br/>Models, Biological<br/>Protein Binding<br/>Purines--administration & dosage<br/>Quinazolines--administration & dosage<br/>Single-Blind Method<br/>Tablets<br/>Tissue Distribution<br/>Young Adult